Stanford University
Showing 28,471-28,480 of 34,930 Results
-
Dimosthenis Sokaras
Div Head/SSRL Chem & Cat Div, Stanford Synchrotron Radiation Lightsource
Current Role at StanfordDriving next-generation synchrotron science to address critical challenges in catalysis, materials innovation, and real-world energy systems. Leads SSRL energy science department efforts, advancing X-ray capabilities and cross-disciplinary programs aligned with national research priorities.
-
Lynn Sokei
Lecturer, Leveling the Learning Landscape
BioLynn Sokei holds a PhD in English from the University of Colorado at Boulder and an MFA in Fiction from Arizona State University.
-
Eric R. Sokol, MD
Professor of Obstetrics and Gynecology (Gynecology and Gynecologic Specialties/Urogynecology) and, by courtesy, of Urology
Current Research and Scholarly InterestsMy research is focused on the development and testing of novel minimally invasive treatment modalities for complex pelvic floor disorders.
-
Elsa Sola
Instructor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsCirrhosis is a common condition and is associated with recurrent complications. Therapeutic options are limited and the management of complications has been similar for the past decades. The only definitive treatment is liver transplantation; however, this is limited by the number of organs and the risk of complications on the waiting list. Patients with cirrhosis present with profound immune disturbances, but to date there are no therapeutic strategies to restore immune responses.
Dr Sola’s research interest if focused on understanding the mechanisms of immune dysfunction in cirrhosis to guide the development of future therapeutic options. With her research background in Hepatology and Immunology, Dr Sola is using novel techniques to improve the understanding of cirrhosis progression. She is leveraging her skills in human organoids to develop cirrhosis-derived immune organoids as a platform for investigating mechanisms of immune dysfunction and screening new therapeutic options.
